Naiem Issa, MD, PhD, FAAD

The panelist discusses how the therapeutic options for atopic dermatitis have expanded significantly with the emergence of targeted biologics, oral agents, and refined topical treatments, transforming the management approach for patients across the disease spectrum.

The panelist discusses how to safely transition a 36-year-old man with a history of systemic corticosteroid use to appropriate oral treatment options while monitoring for potential complications.

The panelist discusses how to evaluate the need for and manage the transition between biologic therapies in a 32-year-old woman with severe atopic dermatitis who has had an inadequate response to initial treatment.

The panelist discusses how to optimize topical therapy selection and application strategies for a young man with mild atopic dermatitis to achieve symptom control and maintain skin barrier function.

The panelist discusses how to effectively communicate the benefits and potential adverse effects of dupilumab treatment to patients and their families to support informed decision-making.

The panelist discusses how to evaluate and select appropriate therapeutic options for a 10-year-old girl while considering factors such as safety, efficacy, and treatment adherence.

The panelist discusses how understanding the diverse manifestations of atopic dermatitis enables health care providers to develop personalized treatment approaches for optimal patient outcomes.

A holistic yet time-efficient approach can help dermatologists recognize early joint pain symptoms associated with psoriasis.

A patient-centered approach ensures that hair loss treatments align with individual goals and medical history.

Naiem Issa, MD, PhD, shared highlights from his sessions on the 1726 nm laser for acne, atopic dermatitis disease modification, advances in hidradenitis suppurativa, and microneedling techniques for vitiligo.

Naiem Issa, MD, PhD, emphasized the importance of increased awareness regarding antibiotic stewardship among dermatologists, as well as the recently updated acne guidelines.